2nd Quarter - Report

VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED

Period 2nd Quarter 2012 Filed Jul 20, 2012 Signed by Samantha Ventimiglia, Senior Director, Government Affairs and Public Policy

Official filing
Firm
VERTEX PHARMACEUTICALS INCORPORATED
Client
VERTEX PHARMACEUTICALS INCORPORATED
Income
—
Expenses
$360,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to raising awareness of Hepatitis C (no specific bills); Viral Hepatitis Testing Act of 2011 (H.R. 3381, S. 1809), all provisions; Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 (H.R. 2405, S. 1855), all provisions; (cont'd next page) Expanding and Promoting Expertise in Review of Rare Treatments Act of 2012 (H.R.4156 , S.2281), all provisions; Transforming the Regulatory Environment to Accelerate Access to Treatments (S.2113), provisions; The Unlocking Lifesaving Treatments for Rare-Diseases Act (H.R.3737), all provisions; The Food and Drug Administration Safety and Innovation Act (S.3187), all provisions; To amend chapter V of the Federal Food, Drug, and Cosmetic Act to expedite the development and review of breakthrough therapies (H.R.5334), all provisions; The FAST Act (H.R.4132), all provisions; The Food and Drug Administration Reform Act of 2012 (H.R.5651), all provisions.

LobbyistCovered position, as disclosed
RACHEL WHITEFORD MACK —
RICHARD WAYNE OLSON —
SAMANTHA VENTIMIGLIA —

Contacted: Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1855 (112th), S. 1809 (112th), H.R. 3381 (112th), S. 2281 (112th), H.R. 4156 (112th), H.R. 5651 (112th), H.R. 5334 (112th), H.R. 3737 (112th), H.R. 4132 (112th), S. 3187 (112th), S. 2113 (112th), H.R. 2405 (112th)

Budget/Appropriations BUD

FY 2013 Labor/HHS/Education Draft, provisions related to viral hepatitis funding, BARDA funding, and funding the Strategic National Stockpile; The Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013 (S.3295), provisions related to viral hepatitis funding, BARDA funding, and funding the Strategic National Stockpile.

LobbyistCovered position, as disclosed
RACHEL WHITEFORD MACK —
RICHARD WAYNE OLSON —
SAMANTHA VENTIMIGLIA —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); SENATE

Bills named: S. 3295 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.